TriMix Laboratories announced the launch of TriMix-gel (prostaglandin E, papaverine, phentolamine) for the treatment of erectile dysfunction for patients who cannot tolerate self-injection with a ...
TriMix Laboratories today announced KRS Global Biotechnology has conducted testing on TriMix-gel compounds which allow the expiration date for patient usage to be extended to 60 days. TriMix-gel has ...
TriMix Laboratories, LLC and KRS Global Biotechnology, INC today announced the availability of TriMix-gel® in a 2000 microgram dose. The joint developmental effort is the result of physicians and ...
CHERRY HILL, N.J., April 30 /PRNewswire/ -- T.J. Harkins, President of TriMix Laboratories LLC, announced today that an abstract related to erectile dysfunction product, TriMix-gel(TM), will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback